M
Milestone Pharmaceuticals Inc. (MIST)
NMS – Real Time Price. Currency in USD
1.75
-0.15 (-8.16%)
Market open: May 13, 2026, 10:25 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.75
-0.15 (-8.16%)
Market open: May 13, 2026, 10:25 AM EDT
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
| Name | Position |
|---|---|
| Dr. David B. Bharucha FACC, M.D., Ph.D. | Chief Medical Officer |
| Dr. Guy Rousseau | SVP of Regulatory Affairs and Quality Management |
| Dr. Philip T. Sager FACC, FAHA, FHRS, M.D. | Chief Medical Advisor & Member of the Scientific Advisory Board |
| Dr. Philippe Douville M.B.A., Ph.D. | Founder, Strategic Advisor & Member of Scientific Advisory Board |
| Mr. Amit Hasija | CFO & Executive VP of Corporate Development |
| Mr. David Sandoval | General Counsel & Chief Compliance Officer |
| Mr. Jeff Moore | Vice President of Sales |
| Mr. Jeffrey Nelson | Chief Operating Officer |
| Mr. Joseph G. Oliveto M.B.A. | CEO, President & Executive Director |
| Mr. Roshan Girglani | Vice President of Marketing |
| Date | Type | Document |
|---|---|---|
| 2026-04-30 | DEF 14A | tm2616218d1_def14a.htm |
| 2026-03-20 | 8-K | tm269403d1_8k.htm |
| 2026-03-20 | 10-K | mist-20251231x10k.htm |
| 2026-01-26 | 8-K | tm263973d1_8k.htm |
| 2026-01-13 | 8-K | tm262948d1_8k.htm |
| 2026-01-06 | 8-K | tm261989d1_8k.htm |
| 2025-12-15 | 8-K | tm2533390d1_8k.htm |
| 2025-11-12 | 8-K | tm2530945d1_8k.htm |
| 2025-08-12 | S-8 | tm2522667d1_s8.htm |
| 2025-07-14 | 8-K | tm2520713d1_8k.htm |